June 7, 2024
CordenPharma, Certest team up to add ionizable lipids to CordenPharma’s complex LNP formulation services
CordenPharma and Certest are partnering up to add ionizable lipids to CordenPharma’s complex LNP formulation services
Pharmaceuticals, Biotechnology and Life Sciences
Author: Dino Mustafić
June 7, 2024
World Food Safety Day, 2024
World Food Safety Day is jointly facilitated
by the Food and Agriculture Organization
of the United Nations (FAO) and the World
Health Organization (WHO), and aims to
draw attention and inspire action to help
prevent, detect and manage foodborne
risks, contributing to food security,
human health, economic prosperity,
agriculture, market access, tourism and
sustainable development.
June 7, 2024
Opdivo plus Yervoy demonstrated improved survival benefit
Bristol Myers Squibb presented results from the Phase 3 CheckMate -9DW trial evaluating the dual immunotherapy combination of Opdivo® (nivolumab) plus Yervoy® (ipilimumab)…
March 1, 2024
Prange Group’s Adragos Pharma acquires Fresenius Kabi production site in Norway
The Prange Group and its affiliate Adragos Pharma have successfully acquired the Fresenius Kabi production site in Halden, Norway, a leading sterile pharmaceutical manufacturing facility. This strategic move signifies a significant step forward for both companies, expanding their global footprint and enhancing their capacity for sterile liquid production.
March 1, 2024
Dupixent shows promise in treating severe asthma
New findings from the VESTIGE trial reveal the effectiveness of Dupixent (dupilumab) in managing uncontrolled moderate-to-severe asthma.
February 29, 2024
OCT adds new director ahead of testing its lead compound in Australia, aiming £1.8bn market
Oxford Cannabinoid Technologies Holdings, the biotech company developing prescription cannabinoid medicines, has appointed Lord Mott OBE as an independent Non-Executive Director, effective immediately.
February 29, 2024
GSK appoints Dr Jeannie Lee to the Board as non-executive director
GSK has appointed Dr Jeannie Lee to the Board of the Company as a Non-Executive Director, who will join the Board on 4 March 2024.
February 28, 2024
Launch of PulseSight Therapeutics: advancing non-viral gene therapy for eye diseases
PulseSight Therapeutics SAS, a biotech company, launches with funding from Pureos Bioventures and ND Capital. It aims to validate its innovative delivery platform by advancing drugs for age-related macular diseases.
February 27, 2024
Akeada, Biological E. Limited in partnership to hasten access to dengue vaccine
A strategic partnership between Akeada and Biological E. Limited aims to hasten access to QDENGA® (Dengue Tetravalent Vaccine [Live, Attenuated]) (TAK-003) multi-dose vials (MDVs) for National Immunization Programs by 2030. MDVs offer cost and logistical benefits, with BE aiming for a manufacturing capacity of 50 million doses yearly to support Takeda’s goal of 100 million doses annually within the decade.
January 12, 2024
UK Approval for AGAMREE in Duchenne muscular dystrophy treatment
Santhera Pharmaceuticals has revealed that AGAMREE (vamorolone) has received approval in the United Kingdom (UK) for treating Duchenne muscular dystrophy (DMD) in patients aged 4 and above, regardless of the underlying mutation and ambulatory status.